Skip to main content

Sanofi agrees to pay $2.9B for Provention Bio

By Yahoo! Finance / Bloomberg  
   March 15, 2023

Sanofi agreed to buy Provention Bio Inc. in a $2.9 billion deal intended to bolster the French drugmaker's portfolio of diabetes medicines with a new therapy recently approved in the U.S.

Full story

Get the latest on healthcare leadership in your inbox.